Pallidohirschioporus biformis Fungal Metabolites and Bioactivity Assay Results

Eight secondary metabolites isolated from the fungus Pallidohirschioporus biformis, including one new natural product. The isolates and three solvent extracts were evaluated in seven in vitro bioactivity assays, such as hyaluronidase and cholinesterase inhibition. The dataset was authored by Suratno Suratno and last updated on June 3, 2026.

Use Cases

• Identify potential hyaluronidase inhibitors based on the reported 91% inhibition by compound 8.
• Study selective butyrylcholinesterase inhibition based on the activity of hydroxydihydrobovolide (3).
• Compare the bioactivity profiles of different solvent extracts (chloroform, n-hexane, methanol) from the same fungal source.
• Analyze the structure-activity relationships of isolated butenolides and triterpenoids.

Strengths

• Includes results from seven distinct in vitro bioactivity assays for each extract and compound.
• Reports the isolation and structural characterization of eight secondary metabolites using NMR and MS analysis.
• Identifies one new natural product (biformolide) and one compound reported from natural sources for the first time.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The 1.6 MB file size suggests a small, document-based dataset rather than a large structured data table.

Provenance

Source

figshare

Collection Method

Isolation and structure determination via NMR and MS analysis of fungal extracts, followed by in vitro bioassays.

Freshness

Last updated 2026-06-03 06:04:46; freshness should be verified.

Geography

Fungus distributed in subtropical to temperate regions of the Northern Hemisphere.